Form 4: Twist Bioscience Corp Executive Robert F. Werner Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4


Robert F. Werner, Chief Accounting Officer of Twist Bioscience Corp, sold 242 shares of common stock on June 6, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Summary

  • On June 6, 2024, Robert F. Werner, the Chief Accounting Officer of Twist Bioscience Corp, sold 242 shares of common stock.
  • The sale was executed at a price of $51.329 per share.
  • The transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
  • Following the transaction, Werner directly owns 39,945 shares of Twist Bioscience Corp.
  • The sale was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction.

Sentiment

Score: 5

Explanation: This is a neutral event. The sale is related to tax obligations and doesn't necessarily reflect a change in the executive's confidence in the company.

Industry Context

This is a routine Form 4 filing, indicating a transaction by a company insider. Such filings are common and provide transparency into the trading activities of company executives.

Stakeholder Impact

  • The impact on shareholders is likely minimal, as the sale is for tax purposes and involves a small number of shares.

Key Dates

DateDescription
06/06/2024Date of the stock sale transaction.
06/10/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.